Changing paradigms in the management of differentiated thyroid cancer
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
Professor Mehanna speaks about the evolving guidelines and practices for the management of differentiated thyroid cancer. In particular Hisham looks at the changing paradigms surrounding incidence rate, personalisation of therapy, risk stratification and follow-up, and mortality. Hisham uses data from various clinical trials and publications to support his discussion.
This lecture was part of the 'thyroid (malignant)' event. It was held at The Royal Society of Medicine in London.
Date of lecture: 1st May 2015
This video is available for iPad via Safari
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.